Moreover, hypocalcemia and hyperphosphatemia, which develop in CKD and are exacerbated in ESKD, can trigger secondary hyperparathyroidism and upregulate FGF23 [23,24]. This evidence concerns the gene FGF23 and hyperphosphatemia.